Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-28 Sale | 2025-03-04 8:10 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 98,434 | $42.2 | $4,153,571 | 2,879,164 (Indirect Direct) | View |
| 2024-12-30 Sale | 2024-12-31 2:05 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 11,727 | $42.23 | $495,231 | 2,748,590 (Indirect Direct) | View |
| 2024-12-10 Sale | 2024-12-11 6:44 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 8,273 | $50 | $413,650 | 2,760,317 (Indirect Direct) | View |
| 2024-09-03 Sale | 2024-09-05 11:53 am | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 20,000 | $55.85 | $1,117,000 | 2,788,582 (Indirect Direct) | View |
| 2024-08-06 Sale | 2024-08-07 2:48 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 20,000 | $50.17 | $1,003,400 | 2,808,582 (Indirect Direct) | View |
| 2024-02-07 Sale | 2024-02-08 3:49 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $45 | $1,350,000 | 2,803,755 (Indirect Direct) | View |
| 2023-12-29 Sale | 2024-01-02 4:07 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $47.87 | $1,436,100 | 2,833,755 (Indirect Direct) | View |
| 2023-10-19 Sale | 2023-10-23 5:14 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 47,853 | $33.52 | $1,604,033 | 2,863,728 (Indirect Direct) | View |
| 2022-12-30 Sale | 2023-01-03 4:45 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 19,582 | $45.57 | $892,352 | 2,824,385 (Indirect Direct) | View |
| 2021-05-03 Sale | 2021-05-05 11:32 am | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $107.8 | $3,234,000 | 2,855,793 (Indirect Direct) | View |
| 2021-03-01 Sale | 2021-03-03 8:36 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $141.8 | $4,254,000 | 2,921,793 (Indirect Direct) | View |
| 2021-01-04 Sale | 2021-01-05 6:45 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $136.9 | $4,107,000 | 2,939,930 (Indirect Direct) | View |
| 2020-11-02 Sale | 2020-11-04 3:44 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $96.82 | $2,904,600 | 2,969,930 (Indirect Direct) | View |
| 2020-09-01 Sale | 2020-09-02 4:26 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $82.63 | $2,478,900 | 3,000,782 (Indirect Direct) | View |
| 2020-07-13 Sale | 2020-07-15 1:22 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 40,000 | $85.35 | $3,414,000 | 3,030,782 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-01 Option Award | 2025-03-04 8:10 pm | N/A 2035-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 229,008 | $0 | 2,879,164 (Direct) | View |
| 2024-12-09 Gift | 2024-12-11 6:44 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 20,000 | $0 | 2,760,317 (Indirect) | View |
| 2024-03-01 Option Award | 2024-03-05 8:06 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 111,654 | $0 | 2,897,992 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 8:06 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 17,417 | $53.69 | 2,897,992 (Direct) | View |
| 2023-10-19 Exercise | 2023-10-23 5:14 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 47,853 | $6.86 | 2,863,728 (Direct) | View |
| 2023-10-19 Exercise | 2023-10-23 5:14 pm | N/A 2023-11-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 47,853 | $0 | 2,863,728 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 7:52 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 16,140 | $45.65 | 2,946,661 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 7:52 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 138,416 | $0 | 2,946,661 (Direct) | View |
| 2022-03-01 Tax Withholding | 2022-03-03 6:06 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 12,162 | $67.37 | 2,936,327 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 6:06 pm | N/A 2032-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 144,401 | $0 | 2,936,327 (Direct) | View |
Ownership | 2022-02-01 1:41 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 0 | $0 | 2,804,088 (Direct) | View |
| 2021-12-10 Ownership | 2022-02-01 1:41 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 50,000 | $0 | 2,804,088 (Indirect) | View |
| 2021-10-14 Tax Withholding | 2021-10-18 6:44 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 853 | $81 | 2,854,088 (Direct) | View |
| 2021-05-06 Tax Withholding | 2021-05-10 6:11 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 852 | $115.71 | 2,854,941 (Direct) | View |
| 2021-03-01 Tax Withholding | 2021-03-03 8:36 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 16,342 | $142.47 | 2,921,793 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 8:36 pm | N/A 2031-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 69,453 | $0 | 2,921,793 (Direct) | View |
| 2020-05-22 Ownership | 2021-02-03 8:03 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 181,670 | $0 | 2,928,682 (Indirect) | View |
| 2020-10-14 Tax Withholding | 2020-10-16 7:23 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 852 | $92.69 | 2,999,930 (Direct) | View |